v3.26.3
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Private Placement [Member]
Series Seed [Member]
Series A [Member]
Series B [Member]
Series C [Member]
Common Stock
Common Stock
Private Placement [Member]
Additional Paid-in Capital
Additional Paid-in Capital
Private Placement [Member]
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance, Temporary equity at Dec. 31, 2024     $ 435 $ 6,179 $ 580 $ 107,065            
Beginning Balance at Dec. 31, 2024 $ (94,554)           $ 1   $ 9,657   $ (104,323) $ 111
Beginning balance, Temporary equity, shares at Dec. 31, 2024     295,467 3,655,374 301,119 73,820,346            
Beginning Balance, shares at Dec. 31, 2024             251,655          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 634               634      
Unrealized loss on short-term investments (111)                     (111)
Net loss (5,306)                   (5,306)  
Ending Balance at Mar. 31, 2025 (99,337)           $ 1   10,291   (109,629)  
Ending balance, Temporary equity at Mar. 31, 2025     $ 435 $ 6,179 $ 580 $ 107,065            
Ending Balance, shares at Mar. 31, 2025             251,655          
Ending balance, Temporary equity, shares at Mar. 31, 2025     295,467 3,655,374 301,119 73,820,346            
Beginning balance, Temporary equity at Dec. 31, 2024     $ 435 $ 6,179 $ 580 $ 107,065            
Beginning Balance at Dec. 31, 2024 (94,554)           $ 1   9,657   (104,323) 111
Beginning balance, Temporary equity, shares at Dec. 31, 2024     295,467 3,655,374 301,119 73,820,346            
Beginning Balance, shares at Dec. 31, 2024             251,655          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net loss (13,733)                      
Ending Balance at Sep. 30, 2025 310,221           $ 3   428,327   (118,056) (53)
Ending Balance, shares at Sep. 30, 2025             25,299,102          
Beginning balance, Temporary equity at Mar. 31, 2025     $ 435 $ 6,179 $ 580 $ 107,065            
Beginning Balance at Mar. 31, 2025 (99,337)           $ 1   10,291   (109,629)  
Beginning balance, Temporary equity, shares at Mar. 31, 2025     295,467 3,655,374 301,119 73,820,346            
Beginning Balance, shares at Mar. 31, 2025             251,655          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 335               335      
Net loss (4,871)                   (4,871)  
Ending Balance at Jun. 30, 2025 (103,873)           $ 1   10,626   (114,500)  
Ending balance, Temporary equity at Jun. 30, 2025     $ 435 $ 6,179 $ 580 $ 107,065            
Ending Balance, shares at Jun. 30, 2025             251,655          
Ending balance, Temporary equity, shares at Jun. 30, 2025     295,467 3,655,374 301,119 73,820,346            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 881               881      
Unrealized loss on short-term investments (53)                     (53)
Temporary Equity, Conversion of preferred stock to common stock, shares     (295,467) (3,655,374) (301,119) (73,820,346)            
Temporary Equity, Conversion of preferred stock to common stock     $ (435) $ (6,179) $ (580) $ (107,065)            
Conversion of preferred stock to common stock, shares             3,191,334          
Conversion of preferred stock to common stock 114,260               114,260      
Shares issued upon exercise of option, shares             6,113          
Shares issued upon exercise of options and warrants 247               247      
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs 302,315           $ 2   302,313      
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs, shares             21,850,000          
Net loss (3,556)                   (3,556)  
Ending Balance at Sep. 30, 2025 310,221           $ 3   428,327   (118,056) (53)
Ending Balance, shares at Sep. 30, 2025             25,299,102          
Beginning Balance at Dec. 31, 2025 301,310           $ 3   430,667   (129,528) 168
Beginning Balance, shares at Dec. 31, 2025             25,299,372          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 2,566               2,566      
Unrealized loss on short-term investments 40                     40
Shares issued upon exercise of options 3               3      
Shares issued upon exercise of option, shares             209          
Shares issued upon exercise of warrants 26               26      
Shares issued upon exercise of warrants, shares             68,675          
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs   $ 93,802               $ 93,802    
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs, shares               3,306,571        
Net loss (19,054)                   (19,054)  
Ending Balance at Mar. 31, 2026 378,693           $ 3   527,064   (148,582) 208
Ending Balance, shares at Mar. 31, 2026             28,674,827          
Beginning Balance at Dec. 31, 2025 $ 301,310           $ 3   430,667   (129,528) 168
Beginning Balance, shares at Dec. 31, 2025             25,299,372          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Shares issued upon exercise of option, shares 4,000                      
Net loss $ (129,723)                      
Ending Balance at Sep. 30, 2026 417,640           $ 3   677,433   (259,251) (545)
Ending Balance, shares at Sep. 30, 2026             32,269,691          
Beginning Balance at Mar. 31, 2026 378,693           $ 3   527,064   (148,582) 208
Beginning Balance, shares at Mar. 31, 2026             28,674,827          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 4,901               4,901      
Unrealized loss on short-term investments (22)                     (22)
Shares issued upon exercise of options 47               47      
Shares issued upon exercise of option, shares             3,136          
Shares issued upon exercise of warrants 398               398      
Shares issued upon exercise of warrants, shares             3,100          
Issuance costs related to private placement   (67)               (67)    
Net loss (51,603)                   (51,603)  
Ending Balance at Jun. 30, 2026 332,347           $ 3   532,343   (200,185) 186
Ending Balance, shares at Jun. 30, 2026             28,681,063          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Share-based compensation expense 3,671               3,671      
Unrealized loss on short-term investments (731)                     (731)
Shares issued upon exercise of options 9               9      
Shares issued upon exercise of option, shares             557          
Shares issued upon exercise of warrants 504               504      
Shares issued upon exercise of warrants, shares             10,511          
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs   $ 140,906               $ 140,906    
Issuance of common stock and pre-funded warrants upon private placement, net of issuance costs, shares               3,577,560        
Net loss (59,066)                   (59,066)  
Ending Balance at Sep. 30, 2026 $ 417,640           $ 3   $ 677,433   $ (259,251) $ (545)
Ending Balance, shares at Sep. 30, 2026             32,269,691